AAPL342.20+0.93 (+0.27%) ▲|ABBV284.74+10.38 (+3.78%) ▲|ABT102.50-0.11 (-0.11%) ▼|ACN216.34+2.78 (+1.30%) ▲|ADBE237.89+1.61 (+0.68%) ▲|AMAT450.34-13.90 (-2.99%) ▼|AMD576.83-28.70 (-4.74%) ▼|AMGN425.84+13.00 (+3.15%) ▲|AMT178.22-1.22 (-0.68%) ▼|AMZN255.32-3.26 (-1.26%) ▼|AVGO348.69-8.62 (-2.41%) ▼|AXP307.82-2.02 (-0.65%) ▼|BA185.05-1.44 (-0.77%) ▼|BAC50.97-2.99 (-5.54%) ▼|BKNG159.37+1.86 (+1.18%) ▲|BLK1,077.72+11.60 (+1.09%) ▲|BMY58.41+1.74 (+3.06%) ▲|BNY136.99-4.04 (-2.86%) ▼|BRK-B521.69+1.10 (+0.21%) ▲|C123.35-1.18 (-0.95%) ▼|CAT752.45-20.33 (-2.63%) ▼|CL91.80+1.85 (+2.06%) ▲|CMCSA20.96+0.08 (+0.36%) ▲|COF195.25-2.83 (-1.43%) ▼|COP141.74+0.84 (+0.60%) ▲|COST975.18+20.55 (+2.15%) ▲|CRM235.56-2.45 (-1.03%) ▼|CSCO114.93-0.14 (-0.12%) ▼|CVS89.87+2.32 (+2.65%) ▲|CVX221.13+3.40 (+1.56%) ▲|DE641.35-8.65 (-1.33%) ▼|DHR224.22+1.38 (+0.62%) ▲|DIS108.26-0.32 (-0.29%) ▼|DUK118.60+0.41 (+0.35%) ▲|EMR160.02-3.48 (-2.13%) ▼|FDX288.59-2.00 (-0.69%) ▼|GD334.04+1.62 (+0.49%) ▲|GE307.81+0.18 (+0.06%) ▲|GEV937.58-66.47 (-6.62%) ▼|GILD151.82+3.90 (+2.64%) ▲|GM82.32-1.69 (-2.01%) ▼|GOOG348.42-1.10 (-0.31%) ▼|GOOGL352.73-1.06 (-0.30%) ▼|GS878.24-13.68 (-1.53%) ▼|HD292.39-1.53 (-0.52%) ▼|HON207.98+0.69 (+0.33%) ▲|IBM230.18-0.60 (-0.26%) ▼|INTC98.94-3.87 (-3.76%) ▼|INTU305.80+4.35 (+1.44%) ▲|ISRG416.53-5.53 (-1.31%) ▼|JNJ251.61+3.00 (+1.21%) ▲|JPM335.26+3.83 (+1.16%) ▲|KO91.54+1.43 (+1.59%) ▲|LIN490.64-1.47 (-0.30%) ▼|LLY1,214.23+47.72 (+4.09%) ▲|LMT517.14+13.12 (+2.60%) ▲|LOW186.60-2.14 (-1.13%) ▼|LRCX288.60-12.51 (-4.15%) ▼|MA605.19+0.39 (+0.06%) ▲|MCD236.12+0.31 (+0.13%) ▲|MDLZ62.42+0.92 (+1.50%) ▲|MDT93.02+0.01 (+0.01%) ▲|META737.88-24.62 (-3.23%) ▼|MMM163.32+0.55 (+0.34%) ▲|MO72.39+0.83 (+1.16%) ▲|MRK147.38+5.40 (+3.80%) ▲|MS180.69-5.95 (-3.19%) ▼|MSFT536.63-6.82 (-1.25%) ▼|MU927.40-25.64 (-2.69%) ▼|NEE78.00-0.23 (-0.29%) ▼|NFLX69.85-0.61 (-0.87%) ▼|NKE34.90-0.43 (-1.22%) ▼|NOW139.31+0.70 (+0.51%) ▲|NVDA222.59-5.93 (-2.60%) ▼|ORCL132.61-10.59 (-7.40%) ▼|PEP128.44+1.14 (+0.90%) ▲|PFE29.19+0.82 (+2.87%) ▲|PG155.26+2.22 (+1.45%) ▲|PLTR204.53-4.14 (-1.98%) ▼|PM202.18+2.89 (+1.45%) ▲|QCOM172.62-4.24 (-2.40%) ▼|RTX186.07+3.05 (+1.66%) ▲|SBUX92.66+0.66 (+0.72%) ▲|SCHW95.93-0.01 (-0.01%) ▼|SO88.88+0.77 (+0.87%) ▲|SPG199.10-1.56 (-0.78%) ▼|T22.94+0.09 (+0.37%) ▲|TMO671.80+8.76 (+1.32%) ▲|TMUS155.28+1.55 (+1.01%) ▲|TSLA365.84-9.40 (-2.50%) ▼|TXN280.90-6.95 (-2.41%) ▼|UBER68.91-2.41 (-3.38%) ▼|UNH389.00+11.24 (+2.98%) ▲|UNP283.00+0.64 (+0.23%) ▲|UPS94.78-0.02 (-0.02%) ▼|USB56.15-0.75 (-1.31%) ▼|V393.23-2.84 (-0.72%) ▼|VZ43.93+0.40 (+0.91%) ▲|WFC79.84-0.90 (-1.11%) ▼|WMT114.70+2.42 (+2.16%) ▲|XOM176.64+2.56 (+1.47%) ▲|AAPL342.20+0.93 (+0.27%) ▲|ABBV284.74+10.38 (+3.78%) ▲|ABT102.50-0.11 (-0.11%) ▼|ACN216.34+2.78 (+1.30%) ▲|ADBE237.89+1.61 (+0.68%) ▲|AMAT450.34-13.90 (-2.99%) ▼|AMD576.83-28.70 (-4.74%) ▼|AMGN425.84+13.00 (+3.15%) ▲|AMT178.22-1.22 (-0.68%) ▼|AMZN255.32-3.26 (-1.26%) ▼|AVGO348.69-8.62 (-2.41%) ▼|AXP307.82-2.02 (-0.65%) ▼|BA185.05-1.44 (-0.77%) ▼|BAC50.97-2.99 (-5.54%) ▼|BKNG159.37+1.86 (+1.18%) ▲|BLK1,077.72+11.60 (+1.09%) ▲|BMY58.41+1.74 (+3.06%) ▲|BNY136.99-4.04 (-2.86%) ▼|BRK-B521.69+1.10 (+0.21%) ▲|C123.35-1.18 (-0.95%) ▼|CAT752.45-20.33 (-2.63%) ▼|CL91.80+1.85 (+2.06%) ▲|CMCSA20.96+0.08 (+0.36%) ▲|COF195.25-2.83 (-1.43%) ▼|COP141.74+0.84 (+0.60%) ▲|COST975.18+20.55 (+2.15%) ▲|CRM235.56-2.45 (-1.03%) ▼|CSCO114.93-0.14 (-0.12%) ▼|CVS89.87+2.32 (+2.65%) ▲|CVX221.13+3.40 (+1.56%) ▲|DE641.35-8.65 (-1.33%) ▼|DHR224.22+1.38 (+0.62%) ▲|DIS108.26-0.32 (-0.29%) ▼|DUK118.60+0.41 (+0.35%) ▲|EMR160.02-3.48 (-2.13%) ▼|FDX288.59-2.00 (-0.69%) ▼|GD334.04+1.62 (+0.49%) ▲|GE307.81+0.18 (+0.06%) ▲|GEV937.58-66.47 (-6.62%) ▼|GILD151.82+3.90 (+2.64%) ▲|GM82.32-1.69 (-2.01%) ▼|GOOG348.42-1.10 (-0.31%) ▼|GOOGL352.73-1.06 (-0.30%) ▼|GS878.24-13.68 (-1.53%) ▼|HD292.39-1.53 (-0.52%) ▼|HON207.98+0.69 (+0.33%) ▲|IBM230.18-0.60 (-0.26%) ▼|INTC98.94-3.87 (-3.76%) ▼|INTU305.80+4.35 (+1.44%) ▲|ISRG416.53-5.53 (-1.31%) ▼|JNJ251.61+3.00 (+1.21%) ▲|JPM335.26+3.83 (+1.16%) ▲|KO91.54+1.43 (+1.59%) ▲|LIN490.64-1.47 (-0.30%) ▼|LLY1,214.23+47.72 (+4.09%) ▲|LMT517.14+13.12 (+2.60%) ▲|LOW186.60-2.14 (-1.13%) ▼|LRCX288.60-12.51 (-4.15%) ▼|MA605.19+0.39 (+0.06%) ▲|MCD236.12+0.31 (+0.13%) ▲|MDLZ62.42+0.92 (+1.50%) ▲|MDT93.02+0.01 (+0.01%) ▲|META737.88-24.62 (-3.23%) ▼|MMM163.32+0.55 (+0.34%) ▲|MO72.39+0.83 (+1.16%) ▲|MRK147.38+5.40 (+3.80%) ▲|MS180.69-5.95 (-3.19%) ▼|MSFT536.63-6.82 (-1.25%) ▼|MU927.40-25.64 (-2.69%) ▼|NEE78.00-0.23 (-0.29%) ▼|NFLX69.85-0.61 (-0.87%) ▼|NKE34.90-0.43 (-1.22%) ▼|NOW139.31+0.70 (+0.51%) ▲|NVDA222.59-5.93 (-2.60%) ▼|ORCL132.61-10.59 (-7.40%) ▼|PEP128.44+1.14 (+0.90%) ▲|PFE29.19+0.82 (+2.87%) ▲|PG155.26+2.22 (+1.45%) ▲|PLTR204.53-4.14 (-1.98%) ▼|PM202.18+2.89 (+1.45%) ▲|QCOM172.62-4.24 (-2.40%) ▼|RTX186.07+3.05 (+1.66%) ▲|SBUX92.66+0.66 (+0.72%) ▲|SCHW95.93-0.01 (-0.01%) ▼|SO88.88+0.77 (+0.87%) ▲|SPG199.10-1.56 (-0.78%) ▼|T22.94+0.09 (+0.37%) ▲|TMO671.80+8.76 (+1.32%) ▲|TMUS155.28+1.55 (+1.01%) ▲|TSLA365.84-9.40 (-2.50%) ▼|TXN280.90-6.95 (-2.41%) ▼|UBER68.91-2.41 (-3.38%) ▼|UNH389.00+11.24 (+2.98%) ▲|UNP283.00+0.64 (+0.23%) ▲|UPS94.78-0.02 (-0.02%) ▼|USB56.15-0.75 (-1.31%) ▼|V393.23-2.84 (-0.72%) ▼|VZ43.93+0.40 (+0.91%) ▲|WFC79.84-0.90 (-1.11%) ▼|WMT114.70+2.42 (+2.16%) ▲|XOM176.64+2.56 (+1.47%) ▲|
24.3 C
New York
Wednesday, October 14, 2026

Tag: source

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., July 11, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to a new employee. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employee entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).

Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls (CMC) related observations that are resolvable

Clarification on Leadership Announcement: Annette Slyman not to join Life Backup Plan as Chief Operating Officer

Aliso Viejo, CA, July 11, 2025 (GLOBE NEWSWIRE) -- Galacxia, Inc., the developer of the Life Backup Plan app, is issuing a clarification to our July 10, 2025 press release. Annette Slyman will not be joining the team in any capacity, due to extenuating circumstances.

AI Mining Takes on Ripple’s XRP: PFMCrypto Launches Zero-Hardware XRP Cloud Mining with Daily Rewards

Mine XRP and more—without hardware—using AI-optimized smart contracts delivering consistent, daily returns in BTC, ETH, DOGE, and USDC.
Mine XRP and more—without hardware—using AI-optimized smart contracts delivering consistent, daily returns in BTC, ETH, DOGE, and USDC.

BJMining Launches XRP-Compatible Cloud Mining Contracts Amid Market Volatility and Increased XRP Demand

When the market no longer gives a definite answer, active value-added is the long-term solution for investors
When the market no longer gives a definite answer, active value-added is the long-term solution for investors

Southside Bancshares, Inc. Announces Second Quarter Earnings Call

TYLER, Texas, July 11, 2025 (GLOBE NEWSWIRE) -- Southside Bancshares, Inc. (“Southside”) (NYSE: SBSI), the holding company for Southside Bank, announced today it will release its second quarter financial results before the market opens on Friday, July 25, 2025. Southside will host a conference call to discuss its results on Friday, July 25, 2025, at 11:00 a.m. CDT.

Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25,...

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities lawsuit.

Levi & Korsinsky Reminds Centene Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 8, 2025 – CNC

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Centene Corporation ("Centene" or the "Company") (NYSE: CNC) of a class action securities lawsuit.

August 11, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against RCKT

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Rocket Pharmaceuticals, Inc. ("Rocket" or the "Company") (NASDAQ: RCKT) of a class action securities lawsuit.

Levi & Korsinsky Notifies Krispy Kreme, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline – DNUT

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Krispy Kreme, Inc. ("Krispy Kreme" or the "Company") (NASDAQ: DNUT) of a class action securities lawsuit.

Organon & Co. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky Before July 22, 2025 to Discuss Your Rights –...

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Organon & Co. ("Organon" or the "Company") (NYSE: OGN) of a class action securities lawsuit.

July 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against IOVA

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Iovance Biotherapeutics, Inc. ("Iovance" or the "Company") (NASDAQ: IOVA) of a class action securities lawsuit.

Class Action Filed Against Reddit, Inc. (RDDT) Seeking Recovery for Investors – Contact Levi & Korsinsky

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Reddit, Inc. ("Reddit, Inc." or the "Company") (NYSE: RDDT) of a class action securities lawsuit.

Class Action Filed Against Vestis Corporation (VSTS) Seeking Recovery for Investors – Contact Levi & Korsinsky

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Vestis Corporation ("Vestis" or the "Company") (NYSE: VSTS) of a class action securities lawsuit.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSource